NO165842C - Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.

Info

Publication number
NO165842C
NO165842C NO851538A NO851538A NO165842C NO 165842 C NO165842 C NO 165842C NO 851538 A NO851538 A NO 851538A NO 851538 A NO851538 A NO 851538A NO 165842 C NO165842 C NO 165842C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogy procedure
cefem compounds
cefem
Prior art date
Application number
NO851538A
Other languages
English (en)
Norwegian (no)
Other versions
NO851538L (no
NO165842B (no
Inventor
Akio Miyake
Masahiro Kondo
Masahiko Fujino
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1984/000212 external-priority patent/WO1985004879A1/ja
Priority claimed from PCT/JP1984/000270 external-priority patent/WO1985005620A1/ja
Priority claimed from PCT/JP1985/000102 external-priority patent/WO1986005184A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to US06/726,438 priority Critical patent/US4788185A/en
Publication of NO851538L publication Critical patent/NO851538L/no
Priority to NO85854730A priority patent/NO167293C/no
Priority to EP86102584A priority patent/EP0203271B1/de
Priority to AT86102584T priority patent/ATE89826T1/de
Priority to DE8686102584T priority patent/DE3688477T2/de
Priority to NO860725A priority patent/NO166283C/no
Priority to AU54168/86A priority patent/AU598728B2/en
Priority to NZ215333A priority patent/NZ215333A/xx
Priority to JP61044991A priority patent/JPS62149682A/ja
Priority to IE54886A priority patent/IE60163B1/en
Priority to GR860575A priority patent/GR860575B/el
Priority to US06/834,969 priority patent/US4864022A/en
Priority to CN86102034A priority patent/CN1030657C/zh
Priority to KR1019860001441A priority patent/KR930007265B1/ko
Priority to HU86853A priority patent/HU198726B/hu
Priority to PCT/JP1986/000099 priority patent/WO1986005183A1/en
Priority to AR86303255A priority patent/AR241534A1/es
Priority to CA000502935A priority patent/CA1295995C/en
Priority to ES552525A priority patent/ES8705892A1/es
Priority to FI860870A priority patent/FI85858C/fi
Priority to PT82123A priority patent/PT82123B/pt
Priority to DK93586A priority patent/DK93586A/da
Priority to ES557183A priority patent/ES8801290A1/es
Priority to ES557182A priority patent/ES8801289A1/es
Priority to US07/331,192 priority patent/US4962100A/en
Priority to AR90316105A priority patent/AR247398A1/es
Priority to JP16978090A priority patent/JPH0730089B2/ja
Publication of NO165842B publication Critical patent/NO165842B/no
Publication of NO165842C publication Critical patent/NO165842C/no
Priority to SU925052288A priority patent/RU2059641C1/ru
Priority to US08/041,849 priority patent/US5409919A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
NO851538A 1984-04-23 1985-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. NO165842C (no)

Priority Applications (29)

Application Number Priority Date Filing Date Title
US06/726,438 US4788185A (en) 1984-04-23 1985-04-23 Cephalosporin compounds
NO85854730A NO167293C (no) 1984-04-23 1985-11-26 Mellomprodukter.
EP86102584A EP0203271B1 (de) 1985-03-01 1986-02-27 Antibakterielle Verbindungen, ihre Herstellung und Verwendung
AT86102584T ATE89826T1 (de) 1985-03-01 1986-02-27 Antibakterielle verbindungen, ihre herstellung und verwendung.
DE8686102584T DE3688477T2 (de) 1985-03-01 1986-02-27 Antibakterielle verbindungen, ihre herstellung und verwendung.
NO860725A NO166283C (no) 1985-03-01 1986-02-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(5-amino-1,2,4-tiadiazol-3-yl)-2(z)-substituertoksyiminoacetamido)-3-(heterocyclylmetyl)-3-cefem-4-karboksylsyrederivater.
ES552525A ES8705892A1 (es) 1985-03-01 1986-02-28 Un metodo para preparar derivados de cefem
FI860870A FI85858C (fi) 1985-03-01 1986-02-28 Foerfarande foer framstaellning av farmaceutiska 3-kondenserade imidazoliumcefemfoereningar.
PT82123A PT82123B (pt) 1985-03-01 1986-02-28 Processo para a preparacao de compostos cefem com propriedades bactericidas e de composicoes farmaceuticas que os contem
NZ215333A NZ215333A (en) 1985-03-01 1986-02-28 Cephem compounds and pharmaceutical compositions
KR1019860001441A KR930007265B1 (ko) 1985-03-01 1986-02-28 항균 화합물의 제조방법
DK93586A DK93586A (da) 1985-03-01 1986-02-28 Cephemforbindelser samt deres fremstilling og anvendelse
JP61044991A JPS62149682A (ja) 1985-03-01 1986-02-28 抗菌性化合物
IE54886A IE60163B1 (en) 1985-03-01 1986-02-28 Antibacterial compounds, their production and use
GR860575A GR860575B (en) 1985-03-01 1986-02-28 Antibacterial compounds their production and use
US06/834,969 US4864022A (en) 1985-04-17 1986-02-28 3-Condensed imidazolium-cephem compounds
CN86102034A CN1030657C (zh) 1985-03-01 1986-02-28 抗菌化合物的生产方法
AU54168/86A AU598728B2 (en) 1985-03-01 1986-02-28 Antibacterial compounds, their production and use
HU86853A HU198726B (en) 1985-04-17 1986-02-28 Process for producing new cefemcarboxylic acid derivatives and antibacterial pharmaceutical compositions comprising same
PCT/JP1986/000099 WO1986005183A1 (en) 1985-03-01 1986-02-28 Antibacterial compounds, their production and use
AR86303255A AR241534A1 (es) 1985-03-01 1986-02-28 Compuestos de 7-(2-(5-amino-1,2,4-tiazol-3-il)-2-alcoxiimino-acetamido)-3-metil-imidazo piridinio o imidazo-pirimidinio-3-cefem-4-carboxilato y sus sales.
CA000502935A CA1295995C (en) 1985-03-01 1986-02-28 Antibacterial compounds, their production and use
ES557182A ES8801289A1 (es) 1985-03-01 1986-11-03 Un metodo para preparar derivados de cefem
ES557183A ES8801290A1 (es) 1985-03-01 1986-11-03 Un metodo para preparar derivados de cefem
US07/331,192 US4962100A (en) 1985-04-17 1989-03-28 3-Condensed imidazolium-cephem compounds
AR90316105A AR247398A1 (es) 1985-03-01 1990-02-07 Procedimiento para preparar compuestos de de 7-(2-(5-amino-1,2,4-tiadiazol-3- il)-2-alcoxiimino-acetamido)-3-metil-imidazopir idio o imidazopiridazinio-3 cefem-4-carboxilato
JP16978090A JPH0730089B2 (ja) 1985-03-01 1990-06-29 抗菌性化合物
SU925052288A RU2059641C1 (ru) 1985-03-01 1992-06-30 Производные цефалоспорина и их фармацевтически приемлемые соли, антибиотическая фармацевтическая композиция, производное цефалоспорина и его аддитивная соль с галоидводородной кислотой
US08/041,849 US5409919A (en) 1985-04-17 1993-04-02 Pharmaceutically acceptable salt of 7B-[2-(5-amino-1,2,4-thio-diazol-3-yl)-2(Z)-metho-xyiminoacetamido]-3-[(imidazo[1,2-b]pyridazinium-1-yl)methyl]-3-cephem-4-carboxylate and composition comprising same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1984/000212 WO1985004879A1 (fr) 1984-04-23 1984-04-23 Nouveaux composes de cephem
PCT/JP1984/000270 WO1985005620A1 (en) 1984-05-25 1984-05-25 Cephem compounds
PCT/JP1985/000102 WO1986005184A1 (en) 1985-03-01 1985-03-01 Antibacterial compound

Publications (3)

Publication Number Publication Date
NO851538L NO851538L (no) 1985-10-24
NO165842B NO165842B (no) 1991-01-07
NO165842C true NO165842C (no) 1991-04-17

Family

ID=27304399

Family Applications (2)

Application Number Title Priority Date Filing Date
NO851538A NO165842C (no) 1984-04-23 1985-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO85854730A NO167293C (no) 1984-04-23 1985-11-26 Mellomprodukter.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO85854730A NO167293C (no) 1984-04-23 1985-11-26 Mellomprodukter.

Country Status (13)

Country Link
EP (1) EP0160252B1 (de)
JP (1) JPH07103130B2 (de)
KR (2) KR920008945B1 (de)
AU (1) AU580995B2 (de)
CA (1) CA1283096C (de)
DE (2) DE3586547D1 (de)
ES (4) ES8606362A1 (de)
FI (1) FI851592L (de)
GR (1) GR850965B (de)
NO (2) NO165842C (de)
NZ (1) NZ211858A (de)
PH (1) PH23134A (de)
PT (1) PT80328B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
DE3688477T2 (de) * 1985-03-01 1993-09-16 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
JP2519054B2 (ja) * 1986-06-09 1996-07-31 武田薬品工業株式会社 新規セフェム化合物
US4921851A (en) * 1986-06-09 1990-05-01 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
DE3707019A1 (de) * 1987-03-05 1988-09-15 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
US4933334A (en) * 1987-12-04 1990-06-12 Takeda Chemical Industries, Ltd. Antibiotic composition
AU615966B2 (en) * 1987-12-04 1991-10-17 Takeda Chemical Industries Ltd. Crystals of cephem hydrochloride
DE69106902T2 (de) * 1990-03-01 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridazine, ihre Herstellung und Verwendung.
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
ATE449775T1 (de) * 2003-04-30 2009-12-15 Trine Pharmaceuticals Inc Carbacephem beta-lactam-antibiotika
AU2009310959B2 (en) 2008-10-31 2015-05-07 Shionogi & Co., Ltd. Cephalosporin having catechol group
MX2012011521A (es) 2010-04-05 2013-03-08 Shionogi & Co Compuestos cefem que tienen un grupo catecol.
TWI547496B (zh) 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
EP0062321B1 (de) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. Cephalosporinderivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate und ihre Ausgangsprodukte
DE3336757A1 (de) * 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AU580995B2 (en) 1989-02-09
PT80328B (en) 1987-02-16
CA1283096C (en) 1991-04-16
ES557129A0 (es) 1987-12-01
PH23134A (en) 1989-05-11
KR850007427A (ko) 1985-12-04
ES542447A0 (es) 1986-04-01
ES549180A0 (es) 1987-07-16
NO167293B (no) 1991-07-15
ES8800950A1 (es) 1987-12-01
PT80328A (en) 1985-05-01
EP0160252A3 (en) 1987-01-14
NO851538L (no) 1985-10-24
NO165842B (no) 1991-01-07
ES8606362A1 (es) 1986-04-01
DE3586547T2 (de) 1993-04-15
AU4170085A (en) 1985-10-31
NO854730L (no) 1985-10-24
GR850965B (de) 1985-11-25
FI851592A0 (fi) 1985-04-22
KR920008953B1 (ko) 1992-10-12
NZ211858A (en) 1988-08-30
FI851592L (fi) 1985-10-24
NO167293C (no) 1991-10-23
EP0160252A2 (de) 1985-11-06
ES8707245A1 (es) 1987-07-16
DE3586547A1 (de) 1993-02-04
EP0160252B1 (de) 1992-08-26
ES553666A0 (es) 1987-06-16
ES8706692A1 (es) 1987-06-16
KR920008945B1 (ko) 1992-10-12
JPH07103130B2 (ja) 1995-11-08
JPS60231684A (ja) 1985-11-18
DE3586547D1 (de) 1993-02-04

Similar Documents

Publication Publication Date Title
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO158060C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser.
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO164654C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (2-okso-1,2,3,5-tetrahydroimidazo (2,1-b)kinazolinyl)-oksylakylamider.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO167923C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidsubstituerte heterocykliske forbindelser
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.
NO163896C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.